Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 8/20 | 0.69 |
| ▸ | CTSL | P07711 | 4/20 | 0.51 |
| ▸ | CTSS | P25774 | 4/20 | 0.51 |
| ▸ | CTSB | P07858 | 3/20 | 0.51 |
| ▸ | CTSK | P43235 | 3/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9825343 | 0.93 | TGM2 (0.75) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL4936394 | 0.93 | TGM2 (0.75) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL4933717 | 0.92 | TGM2 (0.62) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL4935845 | 0.91 | TGM2 (0.73) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL4937443 | 0.91 | TGM2 (0.82) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL9825778 | 0.91 | TGM2 (0.84) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL9825687 | 0.91 | TGM2 (0.84) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL9825959 | 0.88 | TGM2 (0.66) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL9825571 | 0.88 | TGM2 (0.66) | TGM2CTSLCTSSCTSBCTSK | |
| SCHEMBL9825541 | 0.88 | TGM2 (0.64) | TGM2CTSLCTSSCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0237082-B1 | 3,5-DISUBSTITUTED 4,5-DIHYDROISOXAZOLES AS TRANSGLUTAMINASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1991-05-29 | — | — | EP | claimed |
| EP-0237082-A2 | 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors | SYNTEX (U.S.A.) INC. (US) | 1987-09-16 | — | — | EP | claimed |
| EP-0237082-B1 | 3,5-DISUBSTITUTED 4,5-DIHYDROISOXAZOLES AS TRANSGLUTAMINASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1991-05-29 | — | — | EP | disclosed |
| US-4929630-A | SKIN DISORDERS, ACNE, 4,5-DIHYDROISOOXAZOLE PEPTIDES | SYNTEX (U.S.A.) INC. (US) | 1990-05-29 | — | — | US | disclosed |
| US-4912120-A | Containing amine and amide substitution | SYNTEX (U.S.A.) INC. (US) | 1990-03-27 | — | — | US | disclosed |
| EP-0237082-A2 | 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors | SYNTEX (U.S.A.) INC. (US) | 1987-09-16 | — | — | EP | disclosed |